Lihong Liu, MS

Shijiazhuang, Heibei

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 3032 - Tumor Immune Microenvironment Remodeling and Prognosis of Patients with Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy with and without Immunotherapy

  Tuesday, October 1, 2024
  12:45 PM – 2:00 PM ET